Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Nilotinib related acute myocardial infarction with nonobstructive coronary arteries: a case report and literature review.

< BACK TO ARCHIVE


2022 Feb 13


BMC Cardiovasc Disord


http://www.ncbi.nlm.nih.gov/pubmed/35152884?dopt=Abstract


22


1

Nilotinib related acute myocardial infarction with nonobstructive coronary arteries: a case report and literature review.

Authors

Nilotinib related acute myocardial infarction with nonobstructive coronary arteries: a case report and literature review.
Chen W, Du B, Liu K, Yu Z, Wang X, Yang P
BMC Cardiovasc Disord. 2022 Feb 13; 22(1):46.
PMID: 35152884.

Abstract

Myocardial Ischemia with No Obstructive Coronary Artery Disease (MINOCA) is a common cause of type 2 acute myocardial infarction (AMI) which requires careful differential diagnosis. Coronary artery spasm (CAS) syndrome is one etiology that can lead to MINOCA. Nilotinib, a targeted treatment for chronic myeloid leukemia (CML), has been reported to be related with increased risk of adverse vascular events.
Read This Paper